108 results
Aflatoxin B1 Sorption and Safety of Dietary Sodium Bentonite in Sprague-Dawley Rats
- Alicia G. Marroquín-Cardona, Youjun Deng, Jose F. Garcia-Mazcorro, Natalie M. Johnson, Nicolle J. Mitchell, Lili Tang, Jia-Sheng Wang, Roger B. Harvey, Timothy D. Phillips
-
- Journal:
- Clays and Clay Minerals / Volume 70 / Issue 2 / April 2022
- Published online by Cambridge University Press:
- 01 January 2024, pp. 165-181
-
- Article
- Export citation
-
Bentonites are readily available clays used in the livestock industry as feed additives to reduce aflatoxin (AF) exposure; their potential interaction with nutrients is the main concern limiting their use, however. The objective of the present study was to determine the safety of a dietary sodium-bentonite (Na-bentonite) supplement as a potential AF adsorbent, using juvenile Sprague Dawley (SD) rats as a research model. Animals were fed either a control diet or a diet containing Na-bentonite at 0.25% and 2% (w/w) inclusion rate. Growth, serum, and blood biochemical parameters, including selected serum vitamins (A and E) and elements such as calcium (Ca), potassium (K), iron (Fe), and zinc (Zn) were measured. The mineral characteristics and the aflatoxin B1 sorption capacity of Na-bentonite were also determined. By the end of the study, males gained more weight than females in control and Na-bentonite groups (p ≤ 0.0001); the interaction between treatment and sex was not significant (p = 0.6780), however. Some significant differences between the control group and bentonite treatments were observed in serum biochemistry and vitamin and minerals measurements; however, parameters fell within reference clinical values reported for SD rats and no evidence of dose-dependency was found. Serum Na and Na/K ratios were increased, while K levels were decreased in males and females from Na-bentonite groups. Serum Zn levels were decreased only in males from Na-bentonite treatments. Overall, results showed that inclusion of Na-bentonite at 0.25% and 2% did not cause any observable toxicity in a 3-month rodent study.
Agricultural Research Service Weed Science Research: Past, Present, and Future
- Stephen L. Young, James V. Anderson, Scott R. Baerson, Joanna Bajsa-Hirschel, Dana M. Blumenthal, Chad S. Boyd, Clyde D. Boyette, Eric B. Brennan, Charles L. Cantrell, Wun S. Chao, Joanne C. Chee-Sanford, Charlie D. Clements, F. Allen Dray, Stephen O. Duke, Kayla M. Eason, Reginald S. Fletcher, Michael R. Fulcher, John F. Gaskin, Brenda J. Grewell, Erik P. Hamerlynck, Robert E. Hoagland, David P. Horvath, Eugene P. Law, John D. Madsen, Daniel E. Martin, Clint Mattox, Steven B. Mirsky, William T. Molin, Patrick J. Moran, Rebecca C. Mueller, Vijay K. Nandula, Beth A. Newingham, Zhiqiang Pan, Lauren M. Porensky, Paul D. Pratt, Andrew J. Price, Brian G. Rector, Krishna N. Reddy, Roger L. Sheley, Lincoln Smith, Melissa C. Smith, Keirith A. Snyder, Matthew A. Tancos, Natalie M. West, Gregory S. Wheeler, Martin M. Williams, Julie Wolf, Carissa L. Wonkka, Alice A. Wright, Jing Xi, Lew H. Ziska
-
- Journal:
- Weed Science / Volume 71 / Issue 4 / July 2023
- Published online by Cambridge University Press:
- 16 August 2023, pp. 312-327
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
The U.S. Department of Agriculture–Agricultural Research Service (USDA-ARS) has been a leader in weed science research covering topics ranging from the development and use of integrated weed management (IWM) tactics to basic mechanistic studies, including biotic resistance of desirable plant communities and herbicide resistance. ARS weed scientists have worked in agricultural and natural ecosystems, including agronomic and horticultural crops, pastures, forests, wild lands, aquatic habitats, wetlands, and riparian areas. Through strong partnerships with academia, state agencies, private industry, and numerous federal programs, ARS weed scientists have made contributions to discoveries in the newest fields of robotics and genetics, as well as the traditional and fundamental subjects of weed–crop competition and physiology and integration of weed control tactics and practices. Weed science at ARS is often overshadowed by other research topics; thus, few are aware of the long history of ARS weed science and its important contributions. This review is the result of a symposium held at the Weed Science Society of America’s 62nd Annual Meeting in 2022 that included 10 separate presentations in a virtual Weed Science Webinar Series. The overarching themes of management tactics (IWM, biological control, and automation), basic mechanisms (competition, invasive plant genetics, and herbicide resistance), and ecosystem impacts (invasive plant spread, climate change, conservation, and restoration) represent core ARS weed science research that is dynamic and efficacious and has been a significant component of the agency’s national and international efforts. This review highlights current studies and future directions that exemplify the science and collaborative relationships both within and outside ARS. Given the constraints of weeds and invasive plants on all aspects of food, feed, and fiber systems, there is an acknowledged need to face new challenges, including agriculture and natural resources sustainability, economic resilience and reliability, and societal health and well-being.
Effect of Lumateperone (ITI-007) on Quality of Life and Functional Disability in the Treatment of Bipolar Depression
- John B Edwards, Suresh Durgam, Susan G Kozauer, Rakesh Jain, Roger S McIntyre
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 2 / April 2023
- Published online by Cambridge University Press:
- 14 April 2023, p. 238
-
- Article
-
- You have access Access
- Export citation
-
Introduction
In patients with bipolar disorder, depression symptoms are associated with greater reduction in function and quality of life than hypomania/mania symptoms. Lumateperone (LUMA), is an FDA-approved antipsychotic to treat schizophrenia and depressive episodes associated with bipolar I or bipolar II disorder.
In a recent phase 3 clinical trial (Study 404, NCT03249376) in people with bipolar depression, LUMA 42 mg monotherapy significantly improved symptoms of depression compared with placebo (PBO). This analysis of Study 404 investigated the effects of LUMA on functional disability and quality of life as measured using the secondary outcome measure, the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF).
MethodsPatients (18–75 years) with bipolar I or bipolar II disorder experiencing a major depressive episode (Montgomery-Åsberg Depression Rating Scale [MADRS] Total score ≥20 and Clinical Global Impression Scale-Bipolar Version-Severity [CGI-BP-S] score ≥4) were randomized to LUMA 42 mg or PBO orally, once daily in the evening for 6 weeks. The primary endpoint was the change from baseline to Day 43 in MADRS Total score, analyzed using a mixed-effects model for repeated measures (MMRM) approach in the intent-to-treat population (ITT). This post hoc analysis evaluated the mean change from baseline to Day 43 in the Q-LES-Q-SF individual item scores using an analysis of covariance with last observation carried forward (ANCOVA-LOCF) in the ITT. Categorical shifts in individual items were also analyzed.
ResultsThe ITT comprised 376 patients (LUMA 42 mg, 188; PBO, 188). Patients in the LUMA 42 mg group had significantly greater improvement on MADRS Total score change from baseline to Day 43 compared with PBO (least squares mean difference vs PBO [LSMD], −4.585; 95% CI, −6.344 to −2.826; effect size vs PBO [ES], −0.56; P<.0001). LUMA 42 mg treatment significantly improved Q-LES-Q-SF Total score from baseline to Day 43 compared with PBO (LSMD, 2.9; 95% CI, 1.15 to 4.59; P=.001).
The Q-LES-Q-SF items with the lowest mean scores at baseline in both groups were mood, leisure time activities, and sexual drive, interest, and/or performance. By Day 43, LUMA 42 mg treatment significantly improved 8 of the 14 items in the Q-LES-Q-SF (P<0.05). Overall life satisfaction also significantly improved with LUMA treatment (P=.0016). The largest improvements with LUMA 42 mg compared with PBO (ES>0.3,) were seen for the ability to function in daily life, family relationships, household activities, leisure time activities, and mood (all LSMD=0.3; all P<.01).
ConclusionIn patients with bipolar depression, treatment with LUMA 42 mg compared with PBO significantly improved patient quality of life and functional impairment. These results support LUMA 42 mg as treatment of MDEs associated with bipolar I or bipolar II disorder in adults.
FundingIntra-Cellular Therapies, Inc.
Building an infrastructure to support the development, conduct, and reporting of informative clinical studies: The Rockefeller University experience
- Rhonda G. Kost, Rita K. Devine, Mark Fernands, Riva Gottesman, Manoj Kandpal, Robert B. MacArthur, Barbara O’Sullivan, Michelle Romanick, Andrea Ronning, Sarah Schlesinger, Jonathan N. Tobin, Roger Vaughan, Maija Neville-Williams, James G. Krueger, Barry S. Coller
-
- Journal:
- Journal of Clinical and Translational Science / Volume 7 / Issue 1 / 2023
- Published online by Cambridge University Press:
- 13 April 2023, e104
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Introduction:
Clinical trials are a vital component of translational science, providing crucial information on the efficacy and safety of new interventions and forming the basis for regulatory approval and/or clinical adoption. At the same time, they are complex to design, conduct, monitor, and report successfully. Concerns over the last two decades about the quality of the design and the lack of completion and reporting of clinical trials, characterized as a lack of “informativeness,” highlighted by the experience during the COVID-19 pandemic, have led to several initiatives to address the serious shortcomings of the United States clinical research enterprise.
Methods and Results:Against this background, we detail the policies, procedures, and programs that we have developed in The Rockefeller University Center for Clinical and Translational Science (CCTS), supported by a Clinical and Translational Science Award (CTSA) program grant since 2006, to support the development, conduct, and reporting of informative clinical studies.
Conclusions:We have focused on building a data-driven infrastructure to both assist individual investigators and bring translational science to each element of the clinical investigation process, with the goal of both generating new knowledge and accelerating the uptake of that knowledge into practice.
Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK
- K. S. Young, K. L. Purves, C. Hübel, M. R. Davies, K. N. Thompson, S. Bristow, G. Krebs, A. Danese, C. Hirsch, C. E. Parsons, E. Vassos, B. N. Adey, S. Bright, L. Hegemann, Y. T. Lee, G. Kalsi, D. Monssen, J. Mundy, A. J. Peel, C. Rayner, H. C. Rogers, A. ter Kuile, C. Ward, K. York, Y. Lin, A. B. Palmos, U. Schmidt, D. Veale, T. R. Nicholson, T. A. Pollak, S. A. M. Stevelink, T. Moukhtarian, A. R. Martineau, H. Holt, B. Maughan, A. Al-Chalabi, K. Ray Chaudhuri, M. P. Richardson, J. R. Bradley, P. F. Chinnery, N. Kingston, S. Papadia, K. E. Stirrups, R. Linger, M. Hotopf, T. C. Eley, G. Breen
-
- Journal:
- Psychological Medicine / Volume 53 / Issue 12 / September 2023
- Published online by Cambridge University Press:
- 26 July 2022, pp. 5428-5441
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Background
The impact of the coronavirus disease 2019 (COVID-19) pandemic on mental health is still being unravelled. It is important to identify which individuals are at greatest risk of worsening symptoms. This study aimed to examine changes in depression, anxiety and post-traumatic stress disorder (PTSD) symptoms using prospective and retrospective symptom change assessments, and to find and examine the effect of key risk factors.
MethodOnline questionnaires were administered to 34 465 individuals (aged 16 years or above) in April/May 2020 in the UK, recruited from existing cohorts or via social media. Around one-third (n = 12 718) of included participants had prior diagnoses of depression or anxiety and had completed pre-pandemic mental health assessments (between September 2018 and February 2020), allowing prospective investigation of symptom change.
ResultsProspective symptom analyses showed small decreases in depression (PHQ-9: −0.43 points) and anxiety [generalised anxiety disorder scale – 7 items (GAD)-7: −0.33 points] and increases in PTSD (PCL-6: 0.22 points). Conversely, retrospective symptom analyses demonstrated significant large increases (PHQ-9: 2.40; GAD-7 = 1.97), with 55% reported worsening mental health since the beginning of the pandemic on a global change rating. Across both prospective and retrospective measures of symptom change, worsening depression, anxiety and PTSD symptoms were associated with prior mental health diagnoses, female gender, young age and unemployed/student status.
ConclusionsWe highlight the effect of prior mental health diagnoses on worsening mental health during the pandemic and confirm previously reported sociodemographic risk factors. Discrepancies between prospective and retrospective measures of changes in mental health may be related to recall bias-related underestimation of prior symptom severity.
Chapter 2 - The Intertidal Zone of the North-East Atlantic Region
-
- By Stephen J. Hawkins, Kathryn E. Pack, Louise B. Firth, Nova Mieszkowska, Ally J. Evans, Gustavo M. Martins, Per Åberg, Leoni C. Adams, Francisco Arenas, Diana M. Boaventura, Katrin Bohn, C. Debora G. Borges, João J. Castro, Ross A. Coleman, Tasman P. Crowe, Teresa Cruz, Mark S. Davies, Graham Epstein, João Faria, João G. Ferreira, Natalie J. Frost, John N. Griffin, ME Hanley, Roger J. H. Herbert, Kieran Hyder, Mark P. Johnson, Fernando P. Lima, Patricia Masterson-Algar, Pippa J. Moore, Paula S. Moschella, Gillian M. Notman, Federica G. Pannacciulli, Pedro A. Ribeiro, Antonio M. Santos, Ana C. F. Silva, Martin W. Skov, Heather Sugden, Maria Vale, Kringpaka Wangkulangkul, Edward J. G. Wort, Richard C. Thompson, Richard G. Hartnoll, Michael T. Burrows, Stuart R. Jenkins
- Edited by Stephen J. Hawkins, Marine Biological Association of the United Kingdom, Plymouth, Katrin Bohn, Louise B. Firth, University of Plymouth, Gray A. Williams, The University of Hong Kong
-
- Book:
- Interactions in the Marine Benthos
- Published online:
- 07 September 2019
- Print publication:
- 29 August 2019, pp 7-46
-
- Chapter
- Export citation
-
Summary
The rocky shores of the north-east Atlantic have been long studied. Our focus is from Gibraltar to Norway plus the Azores and Iceland. Phylogeographic processes shape biogeographic patterns of biodiversity. Long-term and broadscale studies have shown the responses of biota to past climate fluctuations and more recent anthropogenic climate change. Inter- and intra-specific species interactions along sharp local environmental gradients shape distributions and community structure and hence ecosystem functioning. Shifts in domination by fucoids in shelter to barnacles/mussels in exposure are mediated by grazing by patellid limpets. Further south fucoids become increasingly rare, with species disappearing or restricted to estuarine refuges, caused by greater desiccation and grazing pressure. Mesoscale processes influence bottom-up nutrient forcing and larval supply, hence affecting species abundance and distribution, and can be proximate factors setting range edges (e.g., the English Channel, the Iberian Peninsula). Impacts of invasive non-native species are reviewed. Knowledge gaps such as the work on rockpools and host–parasite dynamics are also outlined.
Addition of milk fat globule membrane-enriched supplement to a high-fat meal attenuates insulin secretion and induction of soluble epoxide hydrolase gene expression in the postprandial state in overweight and obese subjects
- Elizabeth Beals, S. G. Kamita, R. Sacchi, E. Demmer, N. Rivera, T. S. Rogers-Soeder, E. R. Gertz, M. D. Van Loan, J. B. German, B. D. Hammock, J. T. Smilowitz, A. M. Zivkovic
-
- Journal:
- Journal of Nutritional Science / Volume 8 / 2019
- Published online by Cambridge University Press:
- 26 April 2019, e16
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
CVD and associated metabolic diseases are linked to chronic inflammation, which can be modified by diet. The objective of the present study was to determine whether there is a difference in inflammatory markers, blood metabolic and lipid panels and lymphocyte gene expression in response to a high-fat dairy food challenge with or without milk fat globule membrane (MFGM). Participants consumed a dairy product-based meal containing whipping cream (WC) high in saturated fat with or without the addition of MFGM, following a 12 h fasting blood draw. Inflammatory markers including IL-6 and C-reactive protein, lipid and metabolic panels and lymphocyte gene expression fold changes were measured using multiplex assays, clinical laboratory services and TaqMan real-time RT-PCR, respectively. Fold changes in gene expression were determined using the Pfaffl method. Response variables were converted into incremental AUC, tested for differences, and corrected for multiple comparisons. The postprandial insulin response was significantly lower following the meal containing MFGM (P < 0·01). The gene encoding soluble epoxide hydrolase (EPHX2) was shown to be more up-regulated in the absence of MFGM (P = 0·009). Secondary analyses showed that participants with higher baseline cholesterol:HDL-cholesterol ratio (Chol:HDL) had a greater reduction in gene expression of cluster of differentiation 14 (CD14) and lymphotoxin β receptor (LTBR) with the WC+MFGM meal. The protein and lipid composition of MFGM is thought to be anti-inflammatory. These exploratory analyses suggest that addition of MFGM to a high-saturated fat meal modifies postprandial insulin response and offers a protective role for those individuals with higher baseline Chol:HDL.
Predicting first-episode psychosis patients who will never relapse over 10 years
- Christy LM Hui, William G Honer, Edwin HM Lee, WC Chang, Sherry KW Chan, Emily SM Chen, Edwin PF Pang, Simon SY Lui, Dicky WS Chung, WS Yeung, Roger MK Ng, William TL Lo, Peter B Jones, Pak Sham, Eric YH Chen
-
- Journal:
- Psychological Medicine / Volume 49 / Issue 13 / October 2019
- Published online by Cambridge University Press:
- 30 October 2018, pp. 2206-2214
-
- Article
- Export citation
-
Background
Although relapse in psychosis is common, a small proportion of patients will not relapse in the long term. We examined the proportion and predictors of patients who never relapsed in the 10 years following complete resolution of positive symptoms from their first psychotic episode.
MethodPatients who previously enrolled in a 12-month randomized controlled trial on medication discontinuation and relapse following first-episode psychosis (FEP) were followed up after 10 years. Relapse of positive symptoms was operationalized as a change from a Clinical Global Impression scale positive score of <3 for at least 3 consecutive months to a score of ⩾3 (mild or more severe). Baseline predictors included basic demographics, premorbid functioning, symptoms, functioning, and neurocognitive functioning.
ResultsOut of 178 first-episode patients, 37 (21%) never relapsed during the 10-year period. Univariate predictors (p ⩽ 0.1) of patients who never relapsed included a duration of untreated psychosis (DUP) ⩽30 days, diagnosed with non-schizophrenia spectrum disorders, having less severe negative symptoms, and performing better in logical memory immediate recall and verbal fluency tests. A multivariate logistic regression analysis further suggested that the absence of any relapsing episodes was significantly related to better short-term verbal memory, shorter DUP, and non-schizophrenia spectrum disorders.
ConclusionsTreatment delay and neurocognitive function are potentially modifiable predictors of good long-term prognosis in FEP. These predictors are informative as they can be incorporated into an optimum risk prediction model in the future, which would help with clinical decision making regarding maintenance treatment in FEP.
The role of phase changes in maintaining pore structure on thermal exposure of aluminosilicate aerogels
- Frances I. Hurwitz, Richard B. Rogers, Haiquan Guo, Kevin Yu, Jennifer Domanowski, Eric Schmid, Meredith G. Fields
-
- Journal:
- MRS Communications / Volume 7 / Issue 3 / September 2017
- Published online by Cambridge University Press:
- 14 September 2017, pp. 642-650
- Print publication:
- September 2017
-
- Article
- Export citation
-
A variety of applications from insulation to catalytic supports can benefit from lightweight, high surface area, mesoporous materials, which maintain their mesoporous structure to temperatures of 900–1200 °C. Silica aerogels begin to densify by 700 °C. Alumina aerogels are capable of higher temperature exposure than their silica counterparts, but undergo successive phase transformations to form transitional aluminas prior densifying to α-alumina. The present study characterizes the phase transitions of aluminosilicate aerogels derived from Boehmite powders to elucidate the role of time and temperature on phase transitions, surface area, and morphology. Aerogel compositions stable to 1200 °C for periods of 24 h have been demonstrated.
Characterization of Black Nightshade (Solanum nigrum) and Related Species in the United States
- A. G. Ogg, Jr., B. S. Rogers, E. E. Schilling
-
- Journal:
- Weed Science / Volume 29 / Issue 1 / January 1981
- Published online by Cambridge University Press:
- 12 June 2017, pp. 27-32
-
- Article
- Export citation
-
Information from taxonomic treatments and comparisons of accessions from numerous locations grown in the field and greenhouse were combined and summarized to produce a key and descriptions of common agricultural nightshades in North America (Solanum americanum Mill., S. nigrum L., S. ptycanthum Dun., and S. sarrachoides Sendt.). Quantitative and qualitative descriptions of key characters and photographs of important morphological structures are provided to facilitate field identification. Problems with nomenclature among these species are discussed, and a system of common names that would standardize usage is proposed.
Native Grass Establishment following Application of Pyridine Herbicides
- Rodney G. Lym, Roger L. Becker, Michael J. Moechnig, Mary B. Halstvedt, Vanelle F. Peterson
-
- Journal:
- Invasive Plant Science and Management / Volume 10 / Issue 1 / March 2017
- Published online by Cambridge University Press:
- 12 April 2017, pp. 110-117
-
- Article
- Export citation
-
Invasive species management is often more successful if desirable species are seeded after the target weed is controlled. However, control of invasive plants must be maintained following reseeding or the seeded species may fail to establish. A regional study conducted in Minnesota, North Dakota, and South Dakota evaluated the effect of aminopyralid, clopyralid, or picloram applied in the fall prior to fall-dormant seeding or seeding the following spring on cool- and warm-season native grass species establishment. Herbicides were applied at standard rates used to control invasive broadleaf weeds in the upper midwestern tallgrass prairie region of the United States. Cool-season species included Canada wildrye, green needlegrass, and intermediate wheatgrass. Warm-season species included big bluestem, little bluestem, sideoats grama, switchgrass, and Indiangrass. Aminopyralid did not reduce seedling establishment in either fall or spring seeding. Grasses generally were not affected by a pretreatment of the pyridine standards clopyralid or picloram either, with the exception of a slight reduction in fall-seeded establishment of intermediate wheatgrass. Picloram also slightly reduced fall-seeded establishment of Canada wildrye. Application of aminopyralid can safely be used to control susceptible invasive species preceding grass species establishment, with a safety margin similar to or slightly better than that with the pyridine standards clopyralid or picloram.
Control of Selected Broadleaf Weeds with Glufosinate as Influenced by Insecticide Coapplication
- Donnie K. Miller, Robert G. Downer, E. Burris, B. Rogers Leonard, Bill J. Williams
-
- Journal:
- Weed Technology / Volume 19 / Issue 3 / September 2005
- Published online by Cambridge University Press:
- 20 January 2017, pp. 719-723
-
- Article
- Export citation
-
Coapplication of herbicides and insecticides affords growers an opportunity to control multiple pests with one application, given that efficacy is not compromised. Glufosinate was applied at 470 g ai/ha both alone and in combination with the insecticides acephate, acetamiprid, bifenthrin, cyfluthrin, dicrotophos, emamectin benzoate, imidacloprid, indoxacarb, lambda-cyhalothrin, methoxyfenozide, spinosad, or thiamethoxam to determine coapplication effects on control of some of the more common and/or troublesome broadleaf weeds infesting cotton. Hemp sesbania, pitted morningglory, prickly sida, redroot pigweed, and sicklepod were treated at the three- to four- or the seven- to eight-leaf growth stage. When applied at the earlier application timing, glufosinate applied alone provided complete control at 14 d after treatment, and control was unaffected by coapplication with insecticides. When glufosinate application was delayed to the later application timing, visual weed control was unaffected by insecticide coapplication. Fresh-weight reduction from the herbicide applied to larger weeds was negatively impacted by addition of the insecticides dicrotophos and imidacloprid with respect to redroot pigweed and prickly sida, but only in one of two experiments. In most cases, delaying application of glufosinate to larger weeds resulted in reduced control compared to that from a three- to four-leaf application, with the extent of reduction varying by species. Results indicate that when applied according to the herbicide label (three- to four-leaf stage), glufosinate/ insecticide coapplications offer producers the ability to integrate pest management strategies and to limit application costs without sacrificing control of the broadleaf weeds evaluated.
Glyphosate–Insecticide Combination Effects on Weed and Insect Control in Cotton
- Joseph H. Pankey, James L. Griffin, B. Rogers Leonard, Donnie K. Miller, Robert G. Downer, Richard W. Costello
-
- Journal:
- Weed Technology / Volume 18 / Issue 3 / September 2004
- Published online by Cambridge University Press:
- 20 January 2017, pp. 698-703
-
- Article
- Export citation
-
Field studies were conducted to evaluate weed control with combinations of glyphosate at 750 g ae/ha and the insecticides acephate (370 g ai/ha), dicrotophos (370 g ai/ha), dimethoate (220 g ai/ha), fipronil (56 g ai/ha), imidacloprid (53 g ai/ha), lambda-cyhalothrin (37 g ai/ha), oxamyl (280 g ai/ha), or endosulfan (420 g ai/ha) and insect control with coapplication of the herbicide with insecticides acephate, dicrotophos, dimethoate, and imidacloprid. Applying lambda-cyhalothrin or fipronil with glyphosate reduced control of hemp sesbania by 19 and 9 percentage points, respectively, compared with glyphosate alone. Acephate, dicrotophos, dimethoate, imidacloprid, lambda-cyhalothrin, oxamyl, and endosulfan did not affect hemp sesbania, pitted morningglory, prickly sida, and redweed control by glyphosate. Lambda-cyhalothrin and fipronil did not affect glyphosate control of weeds other than hemp sesbania. Addition of glyphosate to dicrotophos improved cotton aphid control 4 d after treatment compared with dicrotophos alone. Thrips control was improved with addition of glyphosate to imidacloprid. Insect control was not reduced by glyphosate regardless of insecticide.
Response of non–bromoxynil-resistant cotton to reduced rates of bromoxynil
- Donnie K. Miller, Robert G. Downer, B. Roger Leonard, E. Merritt Holman, Steve T. Kelly
-
- Journal:
- Weed Science / Volume 51 / Issue 5 / October 2003
- Published online by Cambridge University Press:
- 20 January 2017, pp. 786-791
-
- Article
- Export citation
-
Field research was conducted for 2 yr to determine the effects of reduced rates of bromoxynil on growth and yield of non–bromoxynil-resistant cotton. Rates of 4.5, 9, 17, 35, 70, and 140 g ha−1, representing 0.008, 0.016, 0.031, 0.063, 0.125, and 0.25 fractions of the maximum labeled use rate per application (560 g ha−1), were applied to cotton at the two-, five-, or nine-node growth stage. Visual injury was reduced because application timing was delayed from two- to five-node stage in all experiments and from five- to nine-node stage in two of three experiments. Although negatively affected at all application timings, plant height reduction response decreased with increasing cotton maturity. Plant dry weight was most negatively affected after application at the two-node stage. Bromoxynil application, based on the node above white flower number, did not result in maturity delays but did promote earlier maturity when applied at 140 g ha−1 to two- and five-node stage cotton in one of the three experiments. Final plant population was reduced only at the two- and five-node timings, with response more pronounced at the initial timing. Seedcotton yield after bromoxynil application at the highest rate to two-leaf cotton was reduced 34% compared with other rates and the nontreated control. Bromoxynil applied to five- or nine-node cotton did not significantly reduce yield.
Response of nonglyphosate-resistant cotton to reduced rates of glyphosate
- Donnie K. Miller, Robert G. Downer, B. Roger Leonard, E. Merritt Holman, Steve T. Kelly
-
- Journal:
- Weed Science / Volume 52 / Issue 1 / February 2004
- Published online by Cambridge University Press:
- 20 January 2017, pp. 178-182
-
- Article
- Export citation
-
Field research was conducted in 1999 and 2000 to determine the effect of reduced glyphosate rates on growth and yield of nonglyphosate-resistant cotton. Rates of 9, 18, 35, 70, 140, and 280 g ha−1, representing 0.008, 0.016, 0.031 0.063, 0.125, and 0.25, respectively, of the maximum use rate per application (1,120 g ha−1), were applied to cotton at the two-, five-, or nine-node growth stage. On the basis of visual injury estimates, cotton was more tolerant to glyphosate at the nine-node than at earlier growth stages. Plant dry weight was reduced with 70 g ha−1 of glyphosate or higher, when applied at the two- and five-node growth stages in two of three experiments. Dry weight was not affected by glyphosate at the nine-node stage. Plant height also was unaffected by glyphosate rates below 70 g ha−1, but height reduction was noted for all growth stages by experiment combinations, with the exception of the nine-node application for both experiments in 2000, with herbicide rates of 70 g ha−1 or higher. Cotton maturity delay, as noted by an increase in node above white flower number, was observed only at the highest glyphosate rate applied to two- and five-node cotton in one of three experiments. Percent open boll data analysis indicated a decreased opportunity of observing an open boll with increasing glyphosate rate, and this effect was greater at the five-node compared with the two- and nine-node stages in two of three experiments. Seedcotton yield after all glyphosate applications was equivalent to that for the nontreated control.
Response of non–glufosinate-resistant cotton to reduced rates of glufosinate
- Donnie K. Miller, Robert G. Downer, B. Roger Leonard, E. Merritt Holman, Steve T. Kelly
-
- Journal:
- Weed Science / Volume 51 / Issue 5 / October 2003
- Published online by Cambridge University Press:
- 20 January 2017, pp. 781-785
-
- Article
- Export citation
-
Field research was conducted for 2 yr to determine the effect of reduced rates of glufosinate on growth and yield of non–glufosinate-resistant cotton. Rates of 3.4, 6.7, 13, 26.5, 52.5, and 105 g ha−1, representing 0.008, 0.016, 0.031, 0.063, 0.125, and 0.25 of an effective use rate (420 g ha−1), were applied to cotton at the two-, five-, or nine-node growth stage. Based on analysis of visual injury, cotton response decreased as application timing was delayed in one of the three experiments. Injury response was increased slightly with application at the five- compared with the two-node growth stage and was not significant for the latest application timing (nine-node stage) in two of three experiments. In two of the three experiments, plant height reduction response was lowest at the five-node stage and greatest at the nine-node stage. Regardless of application timing, plant dry weight was negatively affected only with the highest rate of glufosinate. Glufosinate application, based on node above white flower number and percent open boll, did not result in a delay in maturity. Final plant population was reduced in all experiments at the two-node application and in one of the three experiments at the five-node stage. Glufosinate application did not adversely affect final plant population when applied to nine-node cotton. Negative effects on cotton growth were not manifested in seedcotton yield reduction after glufosinate application.
Ionospheric Modelling using GPS to Calibrate the MWA. I: Comparison of First Order Ionospheric Effects between GPS Models and MWA Observations
- Part of
- B. S. Arora, J. Morgan, S. M. Ord, S. J. Tingay, N. Hurley-Walker, M. Bell, G. Bernardi, N. D. R. Bhat, F. Briggs, J. R. Callingham, A. A. Deshpande, K. S. Dwarakanath, A. Ewall-Wice, L. Feng, B.-Q. For, P. Hancock, B. J. Hazelton, L. Hindson, D. Jacobs, M. Johnston-Hollitt, A. D. Kapińska, N. Kudryavtseva, E. Lenc, B. McKinley, D. Mitchell, D. Oberoi, A. R. Offringa, B. Pindor, P. Procopio, J. Riding, L. Staveley-Smith, R. B. Wayth, C. Wu, Q. Zheng, J. D. Bowman, R. J. Cappallo, B. E. Corey, D. Emrich, R. Goeke, L. J. Greenhill, D. L. Kaplan, J. C. Kasper, E. Kratzenberg, C. J. Lonsdale, M. J. Lynch, S. R. McWhirter, M. F. Morales, E. Morgan, T. Prabu, A. E. E. Rogers, A. Roshi, N. Udaya Shankar, K. S. Srivani, R. Subrahmanyan, M. Waterson, R. L. Webster, A. R. Whitney, A. Williams, and C. L. Williams
-
- Journal:
- Publications of the Astronomical Society of Australia / Volume 32 / 2015
- Published online by Cambridge University Press:
- 10 August 2015, e029
-
- Article
-
- You have access Access
- HTML
- Export citation
-
We compare first-order (refractive) ionospheric effects seen by the MWA with the ionosphere as inferred from GPS data. The first-order ionosphere manifests itself as a bulk position shift of the observed sources across an MWA field of view. These effects can be computed from global ionosphere maps provided by GPS analysis centres, namely the CODE. However, for precision radio astronomy applications, data from local GPS networks needs to be incorporated into ionospheric modelling. For GPS observations, the ionospheric parameters are biased by GPS receiver instrument delays, among other effects, also known as receiver DCBs. The receiver DCBs need to be estimated for any non-CODE GPS station used for ionosphere modelling. In this work, single GPS station-based ionospheric modelling is performed at a time resolution of 10 min. Also the receiver DCBs are estimated for selected Geoscience Australia GPS receivers, located at Murchison Radio Observatory, Yarragadee, Mount Magnet and Wiluna. The ionospheric gradients estimated from GPS are compared with that inferred from MWA. The ionospheric gradients at all the GPS stations show a correlation with the gradients observed with the MWA. The ionosphere estimates obtained using GPS measurements show promise in terms of providing calibration information for the MWA.
GLEAM: The GaLactic and Extragalactic All-Sky MWA Survey
- Part of
- R. B. Wayth, E. Lenc, M. E. Bell, J. R. Callingham, K. S. Dwarakanath, T. M. O. Franzen, B.-Q. For, B. Gaensler, P. Hancock, L. Hindson, N. Hurley-Walker, C. A. Jackson, M. Johnston-Hollitt, A. D. Kapińska, B. McKinley, J. Morgan, A. R. Offringa, P. Procopio, L. Staveley-Smith, C. Wu, Q. Zheng, C. M. Trott, G. Bernardi, J. D. Bowman, F. Briggs, R. J. Cappallo, B. E. Corey, A. A. Deshpande, D. Emrich, R. Goeke, L. J. Greenhill, B. J. Hazelton, D. L. Kaplan, J. C. Kasper, E. Kratzenberg, C. J. Lonsdale, M. J. Lynch, S. R. McWhirter, D. A. Mitchell, M. F. Morales, E. Morgan, D. Oberoi, S. M. Ord, T. Prabu, A. E. E. Rogers, A. Roshi, N. Udaya Shankar, K. S. Srivani, R. Subrahmanyan, S. J. Tingay, M. Waterson, R. L. Webster, A. R. Whitney, A. Williams, C. L. Williams
-
- Journal:
- Publications of the Astronomical Society of Australia / Volume 32 / 2015
- Published online by Cambridge University Press:
- 22 June 2015, e025
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
GLEAM, the GaLactic and Extragalactic All-sky MWA survey, is a survey of the entire radio sky south of declination + 25° at frequencies between 72 and 231 MHz, made with the MWA using a drift scan method that makes efficient use of the MWA’s very large field-of-view. We present the observation details, imaging strategies, and theoretical sensitivity for GLEAM. The survey ran for two years, the first year using 40-kHz frequency resolution and 0.5-s time resolution; the second year using 10-kHz frequency resolution and 2 s time resolution. The resulting image resolution and sensitivity depends on observing frequency, sky pointing, and image weighting scheme. At 154 MHz, the image resolution is approximately 2.5 × 2.2/cos (δ + 26.7°) arcmin with sensitivity to structures up to ~ 10° in angular size. We provide tables to calculate the expected thermal noise for GLEAM mosaics depending on pointing and frequency and discuss limitations to achieving theoretical noise in Stokes I images. We discuss challenges, and their solutions, that arise for GLEAM including ionospheric effects on source positions and linearly polarised emission, and the instrumental polarisation effects inherent to the MWA’s primary beam.
(Ton)silly seasons? Do atmospheric conditions actually affect post-tonsillectomy secondary haemorrhage rates?
- B Cadd, M Rogers, H Patel, G Crossland
-
- Journal:
- The Journal of Laryngology & Otology / Volume 129 / Issue 7 / July 2015
- Published online by Cambridge University Press:
- 05 June 2015, pp. 702-705
- Print publication:
- July 2015
-
- Article
- Export citation
-
Background:
Tonsillectomy is a common procedure, with potentially life-threatening complications. Previous investigations into post-tonsillectomy secondary haemorrhage rates suggest an influence of climactic and atmospheric conditions on haemorrhage rate, particularly temperature and water vapour pressure. With a single emergency department and a large variance in atmospheric conditions, Darwin, Australia, is ideal for investigating the effects of local climate on rates of post-operative haemorrhage.
Methods:A five-year retrospective review was conducted of all tonsillectomy procedures performed between 2008 and 2013. Effects of atmospheric variables were examined using Pearson's correlation coefficient and analysis of variance.
Results:A total of 941 patients underwent tonsillectomy in the study period. The bleeding rate was 7.7 per cent. No variation was found between wet and dry season tonsillectomies (p = 0.4). Temperature (p = 0.74), water vapour pressure (p = 0.94) and humidity (p = 0.66) had no effect on bleeding.
Conclusion:The findings revealed no correlation between humidity, season, water vapour pressure and haemorrhage rates. Further research should use multi-site data to investigate the effect of air conditioning, humidification and climactic conditions between different regions in Australia.
Contributors
-
- By Mitchell Aboulafia, Frederick Adams, Marilyn McCord Adams, Robert M. Adams, Laird Addis, James W. Allard, David Allison, William P. Alston, Karl Ameriks, C. Anthony Anderson, David Leech Anderson, Lanier Anderson, Roger Ariew, David Armstrong, Denis G. Arnold, E. J. Ashworth, Margaret Atherton, Robin Attfield, Bruce Aune, Edward Wilson Averill, Jody Azzouni, Kent Bach, Andrew Bailey, Lynne Rudder Baker, Thomas R. Baldwin, Jon Barwise, George Bealer, William Bechtel, Lawrence C. Becker, Mark A. Bedau, Ernst Behler, José A. Benardete, Ermanno Bencivenga, Jan Berg, Michael Bergmann, Robert L. Bernasconi, Sven Bernecker, Bernard Berofsky, Rod Bertolet, Charles J. Beyer, Christian Beyer, Joseph Bien, Joseph Bien, Peg Birmingham, Ivan Boh, James Bohman, Daniel Bonevac, Laurence BonJour, William J. Bouwsma, Raymond D. Bradley, Myles Brand, Richard B. Brandt, Michael E. Bratman, Stephen E. Braude, Daniel Breazeale, Angela Breitenbach, Jason Bridges, David O. Brink, Gordon G. Brittan, Justin Broackes, Dan W. Brock, Aaron Bronfman, Jeffrey E. Brower, Bartosz Brozek, Anthony Brueckner, Jeffrey Bub, Lara Buchak, Otavio Bueno, Ann E. Bumpus, Robert W. Burch, John Burgess, Arthur W. Burks, Panayot Butchvarov, Robert E. Butts, Marina Bykova, Patrick Byrne, David Carr, Noël Carroll, Edward S. Casey, Victor Caston, Victor Caston, Albert Casullo, Robert L. Causey, Alan K. L. Chan, Ruth Chang, Deen K. Chatterjee, Andrew Chignell, Roderick M. Chisholm, Kelly J. Clark, E. J. Coffman, Robin Collins, Brian P. Copenhaver, John Corcoran, John Cottingham, Roger Crisp, Frederick J. Crosson, Antonio S. Cua, Phillip D. Cummins, Martin Curd, Adam Cureton, Andrew Cutrofello, Stephen Darwall, Paul Sheldon Davies, Wayne A. Davis, Timothy Joseph Day, Claudio de Almeida, Mario De Caro, Mario De Caro, John Deigh, C. F. Delaney, Daniel C. Dennett, Michael R. DePaul, Michael Detlefsen, Daniel Trent Devereux, Philip E. Devine, John M. Dillon, Martin C. Dillon, Robert DiSalle, Mary Domski, Alan Donagan, Paul Draper, Fred Dretske, Mircea Dumitru, Wilhelm Dupré, Gerald Dworkin, John Earman, Ellery Eells, Catherine Z. Elgin, Berent Enç, Ronald P. Endicott, Edward Erwin, John Etchemendy, C. Stephen Evans, Susan L. Feagin, Solomon Feferman, Richard Feldman, Arthur Fine, Maurice A. Finocchiaro, William FitzPatrick, Richard E. Flathman, Gvozden Flego, Richard Foley, Graeme Forbes, Rainer Forst, Malcolm R. Forster, Daniel Fouke, Patrick Francken, Samuel Freeman, Elizabeth Fricker, Miranda Fricker, Michael Friedman, Michael Fuerstein, Richard A. Fumerton, Alan Gabbey, Pieranna Garavaso, Daniel Garber, Jorge L. A. Garcia, Robert K. Garcia, Don Garrett, Philip Gasper, Gerald Gaus, Berys Gaut, Bernard Gert, Roger F. Gibson, Cody Gilmore, Carl Ginet, Alan H. Goldman, Alvin I. Goldman, Alfonso Gömez-Lobo, Lenn E. Goodman, Robert M. Gordon, Stefan Gosepath, Jorge J. E. Gracia, Daniel W. Graham, George A. Graham, Peter J. Graham, Richard E. Grandy, I. Grattan-Guinness, John Greco, Philip T. Grier, Nicholas Griffin, Nicholas Griffin, David A. Griffiths, Paul J. Griffiths, Stephen R. Grimm, Charles L. Griswold, Charles B. Guignon, Pete A. Y. Gunter, Dimitri Gutas, Gary Gutting, Paul Guyer, Kwame Gyekye, Oscar A. Haac, Raul Hakli, Raul Hakli, Michael Hallett, Edward C. Halper, Jean Hampton, R. James Hankinson, K. R. Hanley, Russell Hardin, Robert M. Harnish, William Harper, David Harrah, Kevin Hart, Ali Hasan, William Hasker, John Haugeland, Roger Hausheer, William Heald, Peter Heath, Richard Heck, John F. Heil, Vincent F. Hendricks, Stephen Hetherington, Francis Heylighen, Kathleen Marie Higgins, Risto Hilpinen, Harold T. Hodes, Joshua Hoffman, Alan Holland, Robert L. Holmes, Richard Holton, Brad W. Hooker, Terence E. Horgan, Tamara Horowitz, Paul Horwich, Vittorio Hösle, Paul Hoβfeld, Daniel Howard-Snyder, Frances Howard-Snyder, Anne Hudson, Deal W. Hudson, Carl A. Huffman, David L. Hull, Patricia Huntington, Thomas Hurka, Paul Hurley, Rosalind Hursthouse, Guillermo Hurtado, Ronald E. Hustwit, Sarah Hutton, Jonathan Jenkins Ichikawa, Harry A. Ide, David Ingram, Philip J. Ivanhoe, Alfred L. Ivry, Frank Jackson, Dale Jacquette, Joseph Jedwab, Richard Jeffrey, David Alan Johnson, Edward Johnson, Mark D. Jordan, Richard Joyce, Hwa Yol Jung, Robert Hillary Kane, Tomis Kapitan, Jacquelyn Ann K. Kegley, James A. Keller, Ralph Kennedy, Sergei Khoruzhii, Jaegwon Kim, Yersu Kim, Nathan L. King, Patricia Kitcher, Peter D. Klein, E. D. Klemke, Virginia Klenk, George L. Kline, Christian Klotz, Simo Knuuttila, Joseph J. Kockelmans, Konstantin Kolenda, Sebastian Tomasz Kołodziejczyk, Isaac Kramnick, Richard Kraut, Fred Kroon, Manfred Kuehn, Steven T. Kuhn, Henry E. Kyburg, John Lachs, Jennifer Lackey, Stephen E. Lahey, Andrea Lavazza, Thomas H. Leahey, Joo Heung Lee, Keith Lehrer, Dorothy Leland, Noah M. Lemos, Ernest LePore, Sarah-Jane Leslie, Isaac Levi, Andrew Levine, Alan E. Lewis, Daniel E. Little, Shu-hsien Liu, Shu-hsien Liu, Alan K. L. Chan, Brian Loar, Lawrence B. Lombard, John Longeway, Dominic McIver Lopes, Michael J. Loux, E. J. Lowe, Steven Luper, Eugene C. Luschei, William G. Lycan, David Lyons, David Macarthur, Danielle Macbeth, Scott MacDonald, Jacob L. Mackey, Louis H. Mackey, Penelope Mackie, Edward H. Madden, Penelope Maddy, G. B. Madison, Bernd Magnus, Pekka Mäkelä, Rudolf A. Makkreel, David Manley, William E. Mann (W.E.M.), Vladimir Marchenkov, Peter Markie, Jean-Pierre Marquis, Ausonio Marras, Mike W. Martin, A. P. Martinich, William L. McBride, David McCabe, Storrs McCall, Hugh J. McCann, Robert N. McCauley, John J. McDermott, Sarah McGrath, Ralph McInerny, Daniel J. McKaughan, Thomas McKay, Michael McKinsey, Brian P. McLaughlin, Ernan McMullin, Anthonie Meijers, Jack W. Meiland, William Jason Melanson, Alfred R. Mele, Joseph R. Mendola, Christopher Menzel, Michael J. Meyer, Christian B. Miller, David W. Miller, Peter Millican, Robert N. Minor, Phillip Mitsis, James A. Montmarquet, Michael S. Moore, Tim Moore, Benjamin Morison, Donald R. Morrison, Stephen J. Morse, Paul K. Moser, Alexander P. D. Mourelatos, Ian Mueller, James Bernard Murphy, Mark C. Murphy, Steven Nadler, Jan Narveson, Alan Nelson, Jerome Neu, Samuel Newlands, Kai Nielsen, Ilkka Niiniluoto, Carlos G. Noreña, Calvin G. Normore, David Fate Norton, Nikolaj Nottelmann, Donald Nute, David S. Oderberg, Steve Odin, Michael O’Rourke, Willard G. Oxtoby, Heinz Paetzold, George S. Pappas, Anthony J. Parel, Lydia Patton, R. P. Peerenboom, Francis Jeffry Pelletier, Adriaan T. Peperzak, Derk Pereboom, Jaroslav Peregrin, Glen Pettigrove, Philip Pettit, Edmund L. Pincoffs, Andrew Pinsent, Robert B. Pippin, Alvin Plantinga, Louis P. Pojman, Richard H. Popkin, John F. Post, Carl J. Posy, William J. Prior, Richard Purtill, Michael Quante, Philip L. Quinn, Philip L. Quinn, Elizabeth S. Radcliffe, Diana Raffman, Gerard Raulet, Stephen L. Read, Andrews Reath, Andrew Reisner, Nicholas Rescher, Henry S. Richardson, Robert C. Richardson, Thomas Ricketts, Wayne D. Riggs, Mark Roberts, Robert C. Roberts, Luke Robinson, Alexander Rosenberg, Gary Rosenkranz, Bernice Glatzer Rosenthal, Adina L. Roskies, William L. Rowe, T. M. Rudavsky, Michael Ruse, Bruce Russell, Lilly-Marlene Russow, Dan Ryder, R. M. Sainsbury, Joseph Salerno, Nathan Salmon, Wesley C. Salmon, Constantine Sandis, David H. Sanford, Marco Santambrogio, David Sapire, Ruth A. Saunders, Geoffrey Sayre-McCord, Charles Sayward, James P. Scanlan, Richard Schacht, Tamar Schapiro, Frederick F. Schmitt, Jerome B. Schneewind, Calvin O. Schrag, Alan D. Schrift, George F. Schumm, Jean-Loup Seban, David N. Sedley, Kenneth Seeskin, Krister Segerberg, Charlene Haddock Seigfried, Dennis M. Senchuk, James F. Sennett, William Lad Sessions, Stewart Shapiro, Tommie Shelby, Donald W. Sherburne, Christopher Shields, Roger A. Shiner, Sydney Shoemaker, Robert K. Shope, Kwong-loi Shun, Wilfried Sieg, A. John Simmons, Robert L. Simon, Marcus G. Singer, Georgette Sinkler, Walter Sinnott-Armstrong, Matti T. Sintonen, Lawrence Sklar, Brian Skyrms, Robert C. Sleigh, Michael Anthony Slote, Hans Sluga, Barry Smith, Michael Smith, Robin Smith, Robert Sokolowski, Robert C. Solomon, Marta Soniewicka, Philip Soper, Ernest Sosa, Nicholas Southwood, Paul Vincent Spade, T. L. S. Sprigge, Eric O. Springsted, George J. Stack, Rebecca Stangl, Jason Stanley, Florian Steinberger, Sören Stenlund, Christopher Stephens, James P. Sterba, Josef Stern, Matthias Steup, M. A. Stewart, Leopold Stubenberg, Edith Dudley Sulla, Frederick Suppe, Jere Paul Surber, David George Sussman, Sigrún Svavarsdóttir, Zeno G. Swijtink, Richard Swinburne, Charles C. Taliaferro, Robert B. Talisse, John Tasioulas, Paul Teller, Larry S. Temkin, Mark Textor, H. S. Thayer, Peter Thielke, Alan Thomas, Amie L. Thomasson, Katherine Thomson-Jones, Joshua C. Thurow, Vzalerie Tiberius, Terrence N. Tice, Paul Tidman, Mark C. Timmons, William Tolhurst, James E. Tomberlin, Rosemarie Tong, Lawrence Torcello, Kelly Trogdon, J. D. Trout, Robert E. Tully, Raimo Tuomela, John Turri, Martin M. Tweedale, Thomas Uebel, Jennifer Uleman, James Van Cleve, Harry van der Linden, Peter van Inwagen, Bryan W. Van Norden, René van Woudenberg, Donald Phillip Verene, Samantha Vice, Thomas Vinci, Donald Wayne Viney, Barbara Von Eckardt, Peter B. M. Vranas, Steven J. Wagner, William J. Wainwright, Paul E. Walker, Robert E. Wall, Craig Walton, Douglas Walton, Eric Watkins, Richard A. Watson, Michael V. Wedin, Rudolph H. Weingartner, Paul Weirich, Paul J. Weithman, Carl Wellman, Howard Wettstein, Samuel C. Wheeler, Stephen A. White, Jennifer Whiting, Edward R. Wierenga, Michael Williams, Fred Wilson, W. Kent Wilson, Kenneth P. Winkler, John F. Wippel, Jan Woleński, Allan B. Wolter, Nicholas P. Wolterstorff, Rega Wood, W. Jay Wood, Paul Woodruff, Alison Wylie, Gideon Yaffe, Takashi Yagisawa, Yutaka Yamamoto, Keith E. Yandell, Xiaomei Yang, Dean Zimmerman, Günter Zoller, Catherine Zuckert, Michael Zuckert, Jack A. Zupko (J.A.Z.)
- Edited by Robert Audi, University of Notre Dame, Indiana
-
- Book:
- The Cambridge Dictionary of Philosophy
- Published online:
- 05 August 2015
- Print publication:
- 27 April 2015, pp ix-xxx
-
- Chapter
- Export citation